In recent years, there has been an increased interest in high dilutions of various substances following the discovery of the released-activity phenomenon. The phenomenon is that releasedactive dilutions acquire a common property-the ability to modify the initial substance both inside and outside the organism.
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The mechanisms of action of high dilutions are explained in the works of V. A. Tverdislov that experimentally describe the formation of two-dimensional quasi-crystalline structures, the pronounced effects of which are attributed not to the concentration dominance of separate components in a homogenous mixture, but to the local prevalence of chirally pure polarized clusters of a dilution component in the near-surface layers.
These conditions may well be associated with distinguishing the released-active forms of investigated compounds and their subsequent functional activity.
This study presents the results of research on compounds (antibodies to interferon-gamma, diclofenac, etc.) in released-active and initial forms describing their antiviral, anti-inflammatory and other types of activity that confirm the extent of their modifying effect, which is used in clinical practice.
